difelikefalin
Showing 1 - 16 of 16
Pruritus, Notalgia Paresthetica Trial in Coral Gables (difelikefalin 2.0 mg tablets, difelikefalin 1.0 mg tablets, difelikefalin
Recruiting
- Pruritus
- Notalgia Paresthetica
- difelikefalin 2.0 mg tablets
- +3 more
-
Coral Gables, FloridaCara Therapeutics Study Site
Aug 3, 2023
End Stage Renal Disease on Hemodialysis Trial in Beijing, Shijiazhuang (Difelikefalin Injection)
Recruiting
- End Stage Renal Disease on Hemodialysis
- Difelikefalin Injection
-
Beijing, China
- +3 more
Jun 1, 2023
Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)
Recruiting
- Chronic Kidney Diseases
- Pruritus
- Difelikefalin 1 mg Oral Tablet
- Placebo Oral Tablet
-
Northridge, California
- +5 more
Dec 21, 2022
Uremic Pruritus Trial in China (Difelikefalin Injection, Placebo Injection)
Recruiting
- Uremic Pruritus
- Difelikefalin Injection
- Placebo Injection
-
Baotou, China
- +34 more
Jun 1, 2023
Pruritus, Atopic Dermatitis Trial (difelikefalin 0.25 mg, difelikefalin 0.5 mg, TCS Cream)
Recruiting
- Pruritus
- Atopic Dermatitis
- difelikefalin 0.25 mg
- +4 more
-
Scottsdale, Arizona
- +36 more
Dec 21, 2022
Pruritus, Atopic Dermatitis Trial in Canada, United States (difelikefalin 0.25 mg, difelikefalin 0.5 mg, difelikefalin 1.0 mg)
Completed
- Pruritus
- Atopic Dermatitis
- difelikefalin 0.25 mg
- +3 more
-
Anniston, Alabama
- +39 more
Mar 30, 2022
Pruritus, Notalgia Paresthetica Trial in Canada, United States (difelikefalin 2.0 mg, Placebo)
Completed
- Pruritus
- Notalgia Paresthetica
- difelikefalin 2.0 mg
- Placebo
-
Fort Smith, Arkansas
- +35 more
Aug 1, 2022
Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)
Recruiting
- Chronic Kidney Diseases
- Pruritus
- Difelikefalin 1 mg Oral Tablet
- Placebo Oral Tablet
-
Huntsville, Alabama
- +51 more
Dec 21, 2022
Healthy Trial in Dallas (CR845 0.5 mcg/kg IV, CR845 3 mcg/kg IV, Moxifloxacin 400 mg Oral Tablet)
Completed
- Healthy
- CR845 0.5 mcg/kg IV
- +3 more
-
Dallas, TexasCara Therapeutics Study Site
Feb 20, 2020
Chronic Kidney Diseases, Pruritus Trial in United States (CR845 0.25 mg Oral Tablet, CR845 0.5 mg Oral Tablet, CR845 1 mg Oral
Completed
- Chronic Kidney Diseases
- Pruritus
- CR845 0.25 mg Oral Tablet
- +3 more
-
Birmingham, Alabama
- +59 more
Oct 22, 2020
Hemodialysis, Healthy Trial in San Antonio ([14C] CR845)
Completed
- Hemodialysis
- Healthy
- [14C] CR845
-
San Antonio, TexasCara Therapeutics Study Site
Jul 23, 2019
Osteoarthritis, Hip, Osteoarthritis, Knee, Arthritis Trial in United States (CR845 tablet 1 mg, CR845 tablet 2.5 mg, CR845
Completed
- Osteoarthritis, Hip
- +5 more
- CR845 tablet 1 mg
- +3 more
-
Birmingham, Alabama
- +34 more
Oct 19, 2020
Uremic Pruritus Trial in United States (CR845 0.5 mcg/kg, CR845 1 mcg/kg, CR845 1.5mcg/kg)
Completed
- Uremic Pruritus
- CR845 0.5 mcg/kg
- +3 more
-
Phoenix, Arizona
- +28 more
Jul 15, 2020
Post Abdominal Surgery Pain Trial in United States (CR845 IV 1 mcg/kg, CR845 IV 0.5 mcg/kg, Placebo IV)
Completed
- Post Abdominal Surgery Pain
- CR845 IV 1 mcg/kg
- +2 more
-
Sheffield, Alabama
- +22 more
May 22, 2019